p53 defies convention again: a p53 mutant that has lost tumor suppression but still can kill

Research output: Contribution to journalComment/debate

Abstract

Loss of tumor suppression by the p53 protein involves altered or abrogated transcriptional activity resulting in a failure to mediate wild-type cellular responses including cell cycle arrest, senescence, and apoptosis. Timofeev et al (2019) make the fascinating finding that a novel p53 cooperativity mutation devoid of DNA binding results in no tumor suppression but surprising retention of an apoptotic response to chemotherapy and other treatments. This shows a need for rethinking how mutant p53-driven tumors are treated in the clinic.

Original languageEnglish
Pages (from-to)e103322
JournalEMBO Journal
Volume38
Issue number20
DOIs
StatePublished - 15 Oct 2019

Fingerprint

Dive into the research topics of 'p53 defies convention again: a p53 mutant that has lost tumor suppression but still can kill'. Together they form a unique fingerprint.

Cite this